Scarica l'app Stockscreener
16.00
1.84%
-0.30
Pre-mercato:
16.09
0.09
+0.56%
Precedente Chiudi:
$16.30
Aprire:
$16.3
Volume 24 ore:
368.31K
Relative Volume:
0.83
Capitalizzazione di mercato:
$5.70B
Reddito:
$5.21B
Utile/perdita netta:
$-211.00M
Rapporto P/E:
-25.89
EPS:
-0.6179
Flusso di cassa netto:
$861.30K
1 W Prestazione:
+1.78%
1M Prestazione:
-2.97%
6M Prestazione:
+1.72%
1 anno Prestazione:
+40.72%
Intervallo 1D:
$15.93
$16.41
Intervallo di 1 settimana:
$15.26
$16.41
Portata 52W:
$10.83
$18.91
Bausch Lomb Corp Stock (BLCO) Company Profile
Nome
Bausch Lomb Corp
Settore
Industria
Telefono
908-541-5456
Indirizzo
520 APPLEWOOD CRESCENT, VAUGHAN
Compare BLCO vs ISRG, BDX, MDLN, ALC, RMD
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
BLCO
Bausch Lomb Corp
|
16.00 | 5.70B | 5.21B | -211.00M | 861.30K | -0.6179 |
ISRG
Intuitive Surgical Inc
|
451.38 | 159.86B | 10.58B | 3.00B | 2.83B | 8.2437 |
BDX
Becton Dickinson Co
|
144.17 | 41.01B | 21.92B | 1.76B | 2.63B | 6.1223 |
MDLN
Medline Inc
|
45.32 | 38.32B | 28.43B | 1.16B | 1.26B | 1.4457 |
ALC
Alcon Inc
|
74.45 | 36.29B | 10.40B | 980.00M | 1.61B | 1.9749 |
RMD
Resmed Inc
|
207.88 | 30.15B | 5.40B | 1.49B | 1.78B | 10.12 |
Bausch Lomb Corp Stock (BLCO) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2026-01-05 | Downgrade | Evercore ISI | Outperform → In-line |
| 2025-12-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2025-12-02 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2025-10-01 | Iniziato | Goldman | Neutral |
| 2025-05-02 | Reiterato | H.C. Wainwright | Buy |
| 2025-03-28 | Downgrade | Wells Fargo | Overweight → Equal Weight |
| 2024-12-11 | Downgrade | Citigroup | Buy → Neutral |
| 2024-12-02 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2024-10-15 | Aggiornamento | Evercore ISI | In-line → Outperform |
| 2024-07-10 | Iniziato | Raymond James | Outperform |
| 2024-05-06 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2024-01-04 | Downgrade | Evercore ISI | Outperform → In-line |
| 2023-12-12 | Iniziato | Stifel | Hold |
| 2023-10-03 | Ripresa | Evercore ISI | Outperform |
| 2023-05-30 | Ripresa | Morgan Stanley | Equal-Weight |
| 2023-03-09 | Iniziato | Needham | Hold |
| 2022-12-21 | Iniziato | Barclays | Equal Weight |
| 2022-09-12 | Iniziato | H.C. Wainwright | Buy |
| 2022-07-26 | Iniziato | RBC Capital Mkts | Outperform |
| 2022-06-24 | Iniziato | Evercore ISI | Outperform |
| 2022-06-06 | Iniziato | Citigroup | Buy |
| 2022-05-31 | Iniziato | Deutsche Bank | Hold |
| 2022-05-31 | Iniziato | Goldman | Neutral |
| 2022-05-31 | Iniziato | Guggenheim | Buy |
| 2022-05-31 | Iniziato | JP Morgan | Neutral |
| 2022-05-31 | Iniziato | Jefferies | Buy |
| 2022-05-31 | Iniziato | Morgan Stanley | Equal-Weight |
| 2022-05-31 | Iniziato | Wells Fargo | Overweight |
| 2022-05-11 | Iniziato | Cowen | Outperform |
Mostra tutto
Bausch Lomb Corp Borsa (BLCO) Ultime notizie
June 1 webinar to detail lens material not seen in 25 years - Stock Titan
Bausch & Lomb Earnings: Vision Care Resilience and Pharmaceutical Rebound Lead Off 2026 - Morningstar
H.C. Wainwright Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Maintains Target Price $20 - 富途牛牛
What Bausch + Lomb (BLCO)'s Upgraded 2026 Outlook and Narrowing Losses Mean For Shareholders - Yahoo Finance
Bausch & Lomb (BLCO) director receives 1,415 restricted share units - Stock Titan
Director at Bausch & Lomb (NYSE: BLCO) granted 1,611 RSUs - Stock Titan
Director John Paulson receives 1,375 RSUs in Bausch & Lomb (NYSE: BLCO) - Stock Titan
Bausch & Lomb (BLCO) director receives 1,375 restricted share units - Stock Titan
A Quick Look at Today's Ratings for Bausch + Lomb Corp.(BLCO.US), With a Forecast Between $16 to $16 - Moomoo
Analysts Offer Insights on Healthcare Companies: Teladoc (TDOC), Align Tech (ALGN) and Bausch + Lomb Corporation (BLCO) - The Globe and Mail
BLCO.CA Stock Price, Quote & Chart | BAUSCH + LOMB CORP (TSX:BLCO) - ChartMill
Bausch & Lomb Corp Q1 2026 Financial Results and Risk Factors – Form 10-Q Highlights - Minichart
BofA Securities Maintains Bausch + Lomb Corp.(BLCO.US) With Sell Rating - 富途牛牛
Stifel Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating, Raises Target Price to $16 - 富途牛牛
Bausch + Lomb (NYSE:BLCO) Issues Earnings Results - MarketBeat
A Quick Look at Today's Ratings for Bausch + Lomb Corp.(BLCO.US), With a Forecast Between $16 to $21 - 富途牛牛
Bausch + Lomb Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
From dry eye to glaucoma, 40+ Bausch + Lomb studies head to Denver - Stock Titan
BofA raises Bausch & Lomb stock price target on earnings beat - Investing.com UK
BofA raises Bausch & Lomb stock price target on earnings beat By Investing.com - Investing.com South Africa
Bausch & Lomb Corp (BLCO) Q1 2026 Earnings Call Highlights: Strong Revenue Growth and ... By GuruFocus - Investing.com Canada
Bausch + Lomb Q1 Earnings Call Highlights - Yahoo Finance
Evercore ISI cuts Bausch & Lomb stock price target on growth outlook - Investing.com UK
Evercore ISI cuts Bausch & Lomb stock price target on growth outlook By Investing.com - Investing.com South Africa
Bausch & Lomb 10-Q: Revenue $1,244M, Loss per Share $(0.20) - TradingView
Bausch + Lomb (BLCO) Q1 2026 revenue rises to $1.24B as loss narrows - Stock Titan
Earnings call transcript: Bausch + Lomb exceeds Q1 2026 earnings expectations By Investing.com - Investing.com South Africa
Bausch + Lomb Corp reports results for the quarter ended March 31Earnings Summary - TradingView
Bausch + Lomb (BLCO) Surpasses Q1 Earnings and Revenue Estimates - Yahoo Finance
Bausch + Lomb (NYSE:BLCO) Posts Better-Than-Expected Sales In Q1 CY2026 - Yahoo Finance
Bausch + Lomb Announces First-Quarter 2026 Results, Raises Guidance Based on Strong Performance and Positive Outlook - The AI Journal
Bausch + Lomb posts Q1 2026 revenue $1.244B, raises FY26 revenue and EBITDA outlook - TradingView
Stronger Q1 2026 drives Bausch + Lomb (NYSE: BLCO) to raise full-year outlook - Stock Titan
bausch + lomb corporation Positive Earnings Pre-Announcements - RTTNews
Bausch + Lomb (BLCO) Q1 Earnings Report Preview: What To Look For - Yahoo Finance
Bausch & Lomb (NYSE: BLCO) executive reports tax-withheld 4,216-share RSU vesting - Stock Titan
RSU tax withholding adjusts Bausch & Lomb (NYSE: BLCO) holdings - Stock Titan
Icahn money manager sues his bosses and Bausch + Lomb over anti-white bias - MSN
RBC Capital Maintains Bausch + Lomb Corp.(BLCO.US) With Buy Rating, Maintains Target Price $21 - Moomoo
Barclays Maintains Bausch + Lomb Corp.(BLCO.US) With Hold Rating, Maintains Target Price $20 - 富途牛牛
Earnings Preview: BLCO to Report Financial Results Pre-market on April 29 - 富途牛牛
20 studies examine B vitamins for macular degeneration as new formula hits U.S. - Stock Titan
Is It Time To Reconsider Bausch + Lomb (BLCO) After Its 28% One-Year Rally? - Yahoo Finance
Bausch + Lomb targets net zero by 2050, trims lens plastic waste - Stock Titan
Bausch + Lomb (BLCO) Projected to Post Quarterly Earnings on Wednesday - MarketBeat
Why Bausch + Lomb (BLCO) Just Strengthened Something Beyond Earnings - Insider Monkey
Bausch + Lomb (BLCO) Q4 2025 Earnings Transcript - The Globe and Mail
Bausch + Lomb Corp stock (CA07174N1090): Why Google Discover changes matter more now - AD HOC NEWS
10 High Growth Canadian Stocks to Buy Now - Insider Monkey
Bausch + Lomb (NYSE:BLCO) Rating Increased to Buy at Wall Street Zen - MarketBeat
Bausch + Lomb Corporation - Baystreet.ca
Bausch Lomb Corp Azioni (BLCO) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.78%
0.44%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):